Cory Berkland, PhD, Orbis Biosciences Co-Founder and Chief Scientific Officer, has demonstrated Orbis’s technology capabilities for over 15 years. Cory has a PhD in Chemical and Biomolecular Engineering from the University of Illinois, Urbana, where he co-invented and developed the Orbis technology. Cory is a Professor in the Department of Chemical and Petroleum Engineering and in the Department of Pharmaceutical Chemistry at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. Cory has published multiple articles that demonstrate Orbis technology’s ability and has developed novel drug delivery approaches within academia and in collaboration with many companies. Cory’s lab has been funded with grant awards from foundations, federal sources, and industry, and he is regularly retained as a drug delivery consultant by pharmaceutical companies. Leveraging this experience, Cory has co-founded three companies, Orbis Biosciences, Savara Pharmaceuticals, and Orion BioScience.
Cory Berkland
